Advertisement
AFIB Novinky na Forexu
Acutus Medical Sees Q4, FY22 Revenues Well Above Estimates; Appoints Takeo Mukai As CFO
Arrhythmia management company Acutus Medical, Inc. (AFIB) announced Monday that it expects revenues for the fourth quarter in a range of approximately $4.7 million to $4.9 million, compared to $4.4 million in the prior-year quarter.
RTTNews
|
Před 843 dny
Acutus Medical Announces FDA Cleared Commercial Launch Of AcQCross Qx System
Arrhythmia management company Acutus Medical, Inc. (AFIB) announced Monday the commercial launch of an expanded suite of left-heart access products to now include the AcQCross Qx system for use with the TruSeal and FXD delivery system for the Watchman LAAC Device.
RTTNews
|
Před 1039 dny
